Skip to main content
. Author manuscript; available in PMC: 2012 Oct 18.
Published in final edited form as: JAMA. 2012 Apr 18;307(15):1593–1601. doi: 10.1001/jama.2012.454

Figure 2.

Figure 2

Kaplan-Meier Survival Curves for Medicare Beneficiaries Diagnosed with Advanced Non-Squamous Non-Small-Cell Lung Cancer, by Year of Diagnosis and First-Line Chemotherapy Administration with or without Bevacizumab

No. at risk Groups Months following the administration of first chemotherapy regimen
0 6 12 18 24 30 36
1 318 225 133 84 54 31 17
2 1182 756 489 328 228 133 68
3 2664 1688 982 652 472 348 283